Vivtex is set to receive research funding, upfront payments, milestone payments up to $2.1bn, and tiered royalties.

NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson ...

Partnership will leverage Vivtex’s proprietary technologies built to identify optimal oral formulations for peptide and ...

Novo Nordisk and Vivtex Corporation have entered into a partnership to develop next-generation oral biologic medicines for ...

PALO ALTO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (ATNF) (“180 Life Sciences” or the “Company”), today announced that an agreement has been reached with Prof. Avi Domb of ...

Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead with oral ...

Gilead Sciences has pulled out of an oral COVID-19 antiviral project, telling Matinas BioPharma that it is focusing on its own approach at the expense of its collaborator’s lipid nanocrystal (LNC) ...

Oral edaravone was developed to have a similar clinical profile as the intravenous formulation Radicava. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug ...

The oral solution is supplied in a 120mL bottle containing 25mg of sitagliptin per mL. Brynovin ™, an oral solution formulation of sitagliptin, is now available from Azurity Pharmaceuticals. Brynovin ...